High doses of botulinum toxin effectively treat disabling up-going toe

Journal of the Neurological Sciences

Volumn 264, Issue 1-2, 2008, Pages 118-120

  Kurtis, M M ^a   Floyd, A G ^a   Yu, Q P ^a   Pullman, S L ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Botulinum toxin; Dystonia; Muscle; Spasticity; Striatal toe; Treatment efficacy; Treatment safety; Up going toe

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; SPASTICITY; UP GOING TOE;

ADULT; AGED; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIC DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; MUSCLE, SKELETAL; TOES; TREATMENT OUTCOME;

EID: 36549009020     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.013     Document Type: Article

References (13)

1. Yelnik A.P., Colle F.M., Bonan I.V., and Lamotte D.R. Disabling overactivity of the extensor hallucis longus after stroke: clinical expression and efficacy of botulinum toxin type A. Arch Phys Med Rehabil 84 (Jan 2003) 147-149
2. Suputtitada A. Local botulinum toxin type A injections in the treatment of spastic toes. Am J Phys Med Rehabil 81 (Oct 2002) 770-775
3. Sherman A.L., Willick S.P., and Cardenas D.D. Management of focal dystonia of the extensor hallucis longus muscle with botulinum toxin injection: a case report. Arch Phys Med Rehabil 79 (Oct 1998) 1303-1305
4. Ashour R., Tintner R., and Jankovic J. Striatal deformities of the hand and foot in Parkinson's disease. Lancet Neurol 4 (Jul 2005) 423-431
5. Rogers J.D., and Pullman S.L. Injections of botulinum toxin A in foot dystonia. Neurology (1993) 329
6. Schneider S.A., Edwards M.J., Grill S.E., Goldstein S., Kanchana S., Quinn N.P., et al. Adult-onset primary lower limb dystonia. Mov Disord 21 (Jun 2006) 767-771
7. Singer C., and Papapetropoulos S. Adult-onset primary focal foot dystonia. Parkinsonism Relat Disord 12 (Jan 2006) 57-60
8. Pacchetti C., Albani G., Martignoni E., Godi L., Alfonsi E., and Nappi G. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord 10 (May 1995) 333-336
9. Jankovic J., and Tintner R. Dystonia and parkinsonism. Parkinsonism Relat Disord 8 (Oct 2001) 109-121
10. Koman L.A., Brashear A., Rosenfeld S., Chambers H., Russman B., Rang M., et al. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 108 (Nov 2001) 1062-1071
11. Giladi N., Meer J., and Honigman S. The use of botulinum toxin to treat "striatal" toes. J Neurol Neurosurg Psychiatry 57 (May 1994) 659
12. Pullman S.L., Greene P., Fahn S., and Pedersen S.F. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Arch Neurol 53 (Jul 1996) 617-624
13. Pullman S.L. Limb dystonia: use of botulinum toxin. In: Jankovic J., and Hallett M. (Eds). Therapeutic Use of Botulinum Toxin (1994), Marcel Dekker, New York